Modulating Astrocytes With Rapamycin to Tackle Neurodegeneration

Astrocytes, a key type of glial cell in the brain, have long been recognised for their supportive role in maintaining neuronal health. However, recent research from the Chinese Academy of Sciences, published in Nature Aging, has offered another perspective: astrocytes exist in dynamic states that can shift from neuroprotective to neurotoxic under inflammatory conditions. This paper sheds light on a potential therapeutic target for neurodegenerative diseases like Alzheimer’s.

A Dynamic Transition: From Protector to Threat

The study, led by Dr Liansheng Zhang and Dr Haibo Zhou, reveals that astrocytes do not strictly exist as neuroprotective (A2) or neurotoxic (A1) subtypes, as previously thought. Instead, they transition between these states, with the neuroprotective phase serving as an intermediate step. Dr. Zhang states, “Our findings redefine astrocyte heterogeneity, showing that neuroprotective substates are transient and can evolve into neurotoxic ones during neuroinflammation.”

Using time-series multi-omic sequencing, the researchers observed that in both ageing and Alzheimer’s models, an imbalance in these substates correlated with disease progression.

The Role of mTOR Signaling

The mammalian target of rapamycin (mTOR) signalling pathway emerged as a crucial regulator of astrocyte transitions. When this pathway was suppressed, the transition to neurotoxic states was delayed. Remarkably, the use of rapamycin, a known mTOR inhibitor, reduced neurotoxic effects in mouse models of neurodegeneration, highlighting the therapeutic potential of targeting this pathway.

Implications for Alzheimer’s and Aging

This study offers interesting implications for understanding and treating neurodegenerative diseases. By modulating mTOR activity in astrocytes, it may be possible to maintain their neuroprotective state longer, delaying or even preventing the onset of neurotoxic effects. This could significantly slow disease progression in Alzheimer’s and other age-related conditions.

The findings also emphasise the importance of maintaining a balance between astrocyte substates for healthy brain function. With further research, interventions targeting astrocyte transitions could become a cornerstone in the fight against neurodegeneration.